LifeRisks
Read the latest commentary and insights on new developments affecting longevity and mortaility risk.
Snaefellsnes Peninsula, Iceland
Filter by:
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…
New Milestone on The Path To A Universal Flu Vac...
The West African Ebola crisis which peaked in 2014 was a near-miss pandemic. Given the slowness of international financial assistance with…
Looking at Long COVID
A sizeable proportion of people who recover from COVID-19 may then go on to experience some lingering symptoms. The most common of these are…
Learning From the 2022 Monkeypox Outbreak
Every unusual hazardous event offers lessons for enhancing risk assessment. Monkeypox has been on the RMS® infectious disease threat horizon…
Make Sense of Mortality Risk With RMS LifeRisks
Understanding and projecting future mortality requires consideration of the widest set of relevant risk drivers, or a view of risk could be…
Launch of New Vaccine Initiative to Dramatically...
On March 10, 2021, in Oslo, Norway, the Coalition for Epidemic Preparedness Innovations (CEPI) – a global partnership between public, private…
Subscribe to Our Newsletter
